Other disorders of purine and pyrimidine metabolism
Non-billable header
E79.8 is a non-billable header code. Use one of the more specific codes below.
Inclusion terms
Includes (from E79)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E79)
- androgen insensitivity syndrome (E34.5-) (from E79)
- congenital adrenal hyperplasia (E25.0) (from E79)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E79)
- Marfan syndrome (Q87.4-) (from E79)
- 5-alpha-reductase deficiency (E29.1) (from E79)
- Ataxia-telangiectasia (Q87.19) (from E79)
- Bloom's syndrome (Q82.8) (from E79)
- Cockayne's syndrome (Q87.19) (from E79)
- calculus of kidney (N20.0) (from E79)
- combined immunodeficiency disorders (D81.-) (from E79)
- Fanconi's anemia (D61.09) (from E79)
- gout (M1A.-, M10.-) (from E79)
- orotaciduric anemia (D53.0) (from E79)
- progeria (E34.8) (from E79)
- Werner's syndrome (E34.8) (from E79)
- xeroderma pigmentosum (Q82.1) (from E79)
Excludes2
Not included here — may be reported together when both conditions exist.
Parent code
- E79Disorders of purine and pyrimidine metabolismHeader